What to watch with VDR and menopause?

The vitamin D receptor (VDR) mediates the effects of vitamin D in the body. During menopause, declining estrogen impairs calcium absorption and bone metabolism, making vitamin D status particularly relevant. Some studies suggest that VDR polymorphisms (e.g., FokI, BsmI, TaqI) may be associated with altered vitamin D metabolism, bone mineral density, and even menopausal symptoms like hot flashes. However, the evidence is mostly mechanistic or from small observational studies; large randomized controlled trials are lacking. There is no proven benefit of VDR genetic testing for managing menopause. A more practical approach is to measure serum 25-hydroxyvitamin D and supplement according to official guidelines (e.g., 800–2000 IU/day depending on baseline). High-dose supplementation without monitoring can cause hypercalcemia. While VDR variants might one day guide personalized dosing, current evidence is insufficient for clinical recommendations. Bottom line: VDR is an interesting but not yet actionable marker for menopause.